Back to Results

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment

Study category: Diabetes & Hormone Disorders

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Location

Childrens Hospital Colorado

Principal Investigator
Natalie Nokoff,  MD

Natalie Nokoff, MD

Study ID

Protocol Number: 20-2113

More information available at ClinicalTrials.gov: NCT04490915

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers